Apollo Medical (AMEH) Set to Announce Quarterly Earnings on Thursday

Apollo Medical (NASDAQ:AMEH – Get Rating) is set to release its earnings data after the market closes on Thursday, May 5th. Apollo Medical has set its FY 2022 guidance at EPS.

Apollo Medical (NASDAQ:AMEH – Get Rating) last announced its quarterly earnings results on Thursday, February 24th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.04. Apollo Medical had a net margin of 9.54% and a return on equity of 17.85%. The company had revenue of $195.10 million for the quarter. During the same quarter in the prior year, the firm earned $0.27 EPS.

Shares of AMEH opened at $38.21 on Friday. The company has a 50-day simple moving average of $45.25 and a two-hundred day simple moving average of $62.91. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.46 and a quick ratio of 3.46. The firm has a market capitalization of $2.14 billion, a PE ratio of 23.59, a price-to-earnings-growth ratio of 1.29 and a beta of 0.37. Apollo Medical has a one year low of $28.55 and a one year high of $133.23.

Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. boosted its position in shares of Apollo Medical by 1.6% in the 4th quarter. BlackRock Inc. now owns 5,960,508 shares of the company’s stock worth $437,979,000 after purchasing an additional 93,156 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Apollo Medical by 13.9% in the 4th quarter. Goldman Sachs Group Inc. now owns 163,431 shares of the company’s stock worth $12,009,000 after purchasing an additional 20,006 shares in the last quarter. Morgan Stanley boosted its position in shares of Apollo Medical by 148.4% in the 2nd quarter. Morgan Stanley now owns 97,894 shares of the company’s stock worth $6,149,000 after purchasing an additional 58,490 shares in the last quarter. Legal & General Group Plc boosted its position in shares of Apollo Medical by 3.6% in the 4th quarter. Legal & General Group Plc now owns 91,435 shares of the company’s stock worth $6,719,000 after purchasing an additional 3,161 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of Apollo Medical by 35.4% in the 4th quarter. Alliancebernstein L.P. now owns 70,626 shares of the company’s stock worth $5,190,000 after purchasing an additional 18,483 shares in the last quarter. Hedge funds and other institutional investors own 30.65% of the company’s stock.

AMEH has been the topic of a number of research analyst reports. Zacks Investment Research downgraded Apollo Medical from a “buy” rating to a “sell” rating in a report on Tuesday, March 1st. Colliers Securities reiterated a “buy” rating on shares of Apollo Medical in a report on Tuesday, March 22nd. Finally, TheStreet downgraded Apollo Medical from a “b-” rating to a “c+” rating in a report on Monday, March 7th.

About Apollo Medical (Get Rating)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Recommended Stories